Haleon plc

HLN

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
HLN
CIK0001900304
SIC2844
SectorManufacturing
Industry CategoryConsumer Goods
Industry GroupPerfumes, Cosmetics And Other Toilet Preparations

Contact

AddressBUILDING 5, FIRST FLOOR, THE HEIGHTS, WEYBRIDGE, X0, KT13 0NY
Website N/A
Phone44 1932 822000
CEON/A
EmployeesN/A

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$14.06 billion
Pre-Tax Income$2.39 billion
Net Income$1.85 billion
Net Income to Common$1.81 billion
EPS$0.20
View All
Balance Sheet
Cash$2.82 billion
Assets$42.97 billion
Liabilities$22.65 billion
Common Equity$20.24 billion
Liabilities & Equity$42.97 billion
View All
Cash Flow Statement
Calculations
NOPAT$2.13 billion
EBITDA$3.04 billion
Price to Earnings$49.81
Price to Book$4.44
ROE8.87%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Burns Market Analysis and Forecast Report 2025-2035 Featuring Pfizer, Perrigo, Kenvue Brands, 3M, Smith+Nephew, Molnlycke, Cardinal Health, Convatec, Haleon, Coloplast, DeRoyal Industries

The global burns market is experiencing significant growth, fueled by rising burn incidences and enhanced awareness of wound care. Increased occurrences of road accidents and industrial mishaps have propelled the demand for comprehensive treatment solutions, including pharmacological therapies and advanced dressings. Innovations in regenerative medicine and digital health platforms are reshaping burn care, improving patient outcomes. Key market players are focusing on R&D and strategic partnersh

Article Link

Haleon (HLN) Constructing £130m Global Oral Health Innovation Center

Haleon plc (NYSE:HLN) is one of the 15 successful spin-off companies. On July 4, the company broke ground on a new £130m Global Oral Health Innovation Center. The company is developing a state-of-the-art facility that focuses on enhancing scientific capabilities, accelerating innovation, and serving as a center for global oral health research. The construction of […]

Article Link

Down 7.4% in 4 Weeks, Here's Why Haleon PLC Sponsored ADR (HLN) Looks Ripe for a Turnaround

Haleon PLC Sponsored ADR (HLN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Article Link

Haleon Breaks Ground on new £130m Global Oral Health Innovation Centre

LONDON, July 04, 2025--This week, Haleon, a global leader in consumer health and maker of leading brands such as Sensodyne, parodontax and Polident, broke ground on its new Global Oral Health Innovation Centre in Weybridge, Surrey. This state-of-the-art facility will enhance Haleon’s science capabilities, accelerate innovation, and serve as a centre of excellence for global oral health research.

Article Link

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks

During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Stock Grader recommendations for 105 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly. This Week’s Ratings Changes: Up

Article Link